GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/Walled-Off Necrosis: Should We Debride Early Rather Than “Drain First”?: Endoscopy | September 2026
7

Walled-Off Necrosis: Should We Debride Early Rather Than “Drain First”?: Endoscopy | September 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated September 1, 2026

What Did the Study Find?

This meta-analysis included 5 randomised trials and 269 patients with walled-off pancreatic necrosis (WON), comparing immediate direct endoscopic necrosectomy (DEN) with drainage followed by step-up necrosectomy when required.

Immediate DEN achieved higher study-defined clinical success (OR 2.56).

Hospital stay was approximately 8 days shorter with immediate DEN.

Overall adverse events were not significantly increased.

Rates of bleeding, organ failure and mortality were similar.

Readmissions and the total number of procedures were also comparable.

However, definitions of clinical success varied across trials, and the overall evidence base remains small.

Why Does It Matter?

The conventional endoscopic strategy for WON is drain first, then necrosectomy only if needed. Earlier removal of solid necrotic material may provide faster source control in selected patients.

GastroAGI Takeaway

Immediate DEN may be better for selected WON—not for every WON. Patients with infected collections and substantial solid necrotic burden may particularly benefit from earlier debridement. These randomised data challenge a rigid step-up approach, but only 269 patients underpin the evidence; patient selection and expert-centre experience remain critical.

Related Q&A

08

High-Risk Adenomas: Can Surveillance Colonoscopy Wait 5 Years Instead of 3?: NEJM | September 2026

What Did the Study Find? The EPoS trial randomized 10,799 patients with high-risk adenomas to first surveillance colonoscopy at 5 years or 3 years after polypectomy. At 5...

09

Clopidogrel and Colonoscopic Polypectomy: Continue or Temporarily Interrupt?: Surgical Endoscopy | September 2026

What Did the Study Find? This meta-analysis included 5 studies and 536 patients undergoing colonoscopic polypectomy while clopidogrel was either continued or temporarily interrupted. Temporary interruption reduced immediate...

10

Robotic Colonoscopy Moves Into the Colon: FDA Clears Triton 1: US FDA | September 2026

What’s New? The FDA has granted 510(k) clearance to the Triton 1 robotic endoscopy system for diagnostic and therapeutic procedures throughout the colon. The platform is cleared for...

11

EUS-Guided Therapy May Reduce Rebleeding From Gastric Varices: Endoscopy | September 2026

Introduction: The optimal endoscopic treatment for gastric varices remains uncertain. Conventional direct cyanoacrylate injection is widely used, while EUS-guided glue and coil-based therapies allow more targeted variceal treatment....

12

EUS-CDS With LAMS Gets Its First Detailed International Procedural Consensus: UEG Journal | September 2026

Introduction: EUS-guided choledochoduodenostomy using lumen-apposing metal stents (EUS-CDS-L) is increasingly used for distal biliary obstruction, particularly after failed ERCP. As the technique moves from rescue therapy toward possible...

13

EUS-RFA for Small Nonfunctioning PanNETs: GIE | September 2026

What Did the Study Find? This 7-center study evaluated EUS-guided radiofrequency ablation (EUS-RFA) in 46 patients with biopsy-proven nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs), predominantly small, well-differentiated grade 1...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer